检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘若彬[1] Liu Ruobin(Department of Anesthesiology,Gansu Provincial People’s Hospital,Lanzhou,730000,Gansu,China)
机构地区:[1]甘肃省人民医院麻醉手术科,甘肃兰州730000
出 处:《中国医学文摘(耳鼻咽喉科学)》2021年第3期75-77,共3页Chinese Medical Digest(Otorhinolaryngology)
摘 要:目的探究耳鼻喉科手术患者应用丙泊酚复合依托咪酯的麻醉效果。方法选择我院2018年4月至2020年11月期间收治的54例耳鼻喉科手术患者为研究对象,依照随机表表法分成两组,使用丙泊酚的27例患者为对照组,使用丙泊酚复合依托咪酯的27例患者为实验组,分析不同麻醉用药对患者产生的影响。结果实验组的拔管时间、睁眼时间明显短于对照组(P<0.05)。对照组在插管即刻、插管后5分钟的HR、平均动脉压均显著高于实验组(P<0.05),且与麻醉诱导前相比,对照组波动较大(P<0.05),而实验组波动较小(P>0.05);两组患者在各时间点的SpO2比较均无统计学意义(P>0.05)。结论丙泊酚复合依托咪酯用于耳鼻喉科手术患者的安全性较高、麻醉效果显著。Objective To explore the anesthesia effect of propofol combined with etomidate in patients undergoing otolaryngology surgery.Methods 54 patients with otolaryngology surgery admitted to our hospital from April 2018 to November 2020 were selected as the research subjects.They were divided into two groups according to the random table method.27 cases of patients using propofol as the control group and 27 cases of patients using propofol combined with etomidate as the experimental group.Analyze the influence of different anesthetic drugs on patients.Results The extubation time and eye opening time in experimental group were significantly shorter than those in control group(P<0.05).HR and mean arterial pressure in the control group immediately after intubation and 5 minutes after intubation were significantly higher than those in the experimental group(P<0.05).Compared with before anesthesia induction,the fluctuation in the control group was greater(P<0.05),but the fluctuation in the experimental group was smaller(P>0.05).There was no statistical significance in SpO2 between the two groups at each time point(P>0.05).Conclusion Propofol combined with etomidate is safe and effective in patients undergoing otolaryngology surgery.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28